The interrelation between lipid profile in chronic HCV patients and their response to antiviral agents

Abstract

Higher baseline lipid parameters and their further elevation starting from week 6 on treatment are good predictors of SVR in HCV patients. Successful HCV therapy with DAAs is associated with a significant increase in lipid parameters.